Mizuho Cuts MKS (NASDAQ:MKSI) Price Target to $330.00

MKS (NASDAQ:MKSI) had its price objective trimmed by Mizuho from $360.00 to $330.00 in a report published on Tuesday morning, Marketbeat.com reports. The brokerage currently has an outperform rating on the scientific and technical instruments company’s stock.

MKSI has been the topic of several other research reports. TD Cowen reissued a “buy” rating on shares of MKS in a research note on Thursday, May 7th. Morgan Stanley raised their price objective on MKS from $374.00 to $442.00 and gave the company an “overweight” rating in a research note on Monday, July 6th. Bank of America lifted their price objective on MKS from $380.00 to $500.00 and gave the stock a “buy” rating in a report on Tuesday, June 23rd. BMO Capital Markets started coverage on MKS in a research report on Tuesday, June 30th. They set an “outperform” rating and a $453.00 target price on the stock. Finally, Wells Fargo & Company upped their target price on MKS from $300.00 to $325.00 and gave the company an “equal weight” rating in a report on Friday, August 7th. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $382.86.

MKS Stock Performance

Shares of MKSI opened at $270.99 on Tuesday. The company has a quick ratio of 0.72, a current ratio of 1.14 and a debt-to-equity ratio of 0.85. MKS has a 52-week low of $97.50 and a 52-week high of $447.62. The company has a 50-day simple moving average of $333.21 and a 200-day simple moving average of $295.82. The company has a market capitalization of $18.32 billion, a PE ratio of 43.22, a P/E/G ratio of 0.58 and a beta of 1.98.

MKS (NASDAQ:MKSI) last released its quarterly earnings data on Wednesday, August 5th. The scientific and technical instruments company reported $3.30 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.39. MKS had a net margin of 10.15% and a return on equity of 24.72%. The firm had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.20 billion. During the same quarter in the previous year, the firm earned $1.77 earnings per share. The firm’s revenue was up 28.3% on a year-over-year basis. MKS has set its Q3 2026 guidance at 3.270-3.890 EPS. Equities research analysts predict that MKS will post 12.96 earnings per share for the current fiscal year.

MKS Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Tuesday, August 25th will be given a $0.25 dividend. The ex-dividend date is Tuesday, August 25th. This represents a $1.00 annualized dividend and a dividend yield of 0.4%. MKS’s dividend payout ratio is currently 15.95%.

Insiders Place Their Bets

In related news, CAO Michelle M. Mccarthy sold 2,434 shares of MKS stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $315.23, for a total transaction of $767,269.82. Following the completion of the sale, the chief accounting officer owned 2 shares in the company, valued at approximately $630.46. This trade represents a 99.92% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP John Edward Williams sold 457 shares of MKS stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $288.31, for a total transaction of $131,757.67. Following the sale, the executive vice president owned 4,098 shares of the company’s stock, valued at approximately $1,181,494.38. This trade represents a 10.03% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 12,891 shares of company stock valued at $3,919,127. Corporate insiders own 0.57% of the company’s stock.

Institutional Investors Weigh In On MKS

Several hedge funds have recently modified their holdings of MKSI. Dorsey Wright & Associates acquired a new stake in shares of MKS during the 1st quarter worth $1,329,000. Fifth Third Bancorp raised its position in shares of MKS by 3,011.9% in the 1st quarter. Fifth Third Bancorp now owns 19,294 shares of the scientific and technical instruments company’s stock worth $4,434,000 after buying an additional 18,674 shares during the period. California Public Employees Retirement System boosted its holdings in MKS by 7.8% in the first quarter. California Public Employees Retirement System now owns 123,288 shares of the scientific and technical instruments company’s stock valued at $28,333,000 after acquiring an additional 8,904 shares during the last quarter. Renaissance Technologies LLC acquired a new position in MKS in the first quarter valued at $23,809,000. Finally, Anson Funds Management LP purchased a new stake in MKS during the first quarter valued at about $3,792,000. 99.79% of the stock is owned by institutional investors and hedge funds.

Key MKS News

Here are the key news stories impacting MKS this week:

• Positive Sentiment: Analysts raised earnings forecasts across multiple periods. Zacks Research increased estimates for Q4 2026 through Q2 2028, including Q4 2026 EPS to $3.56 from $3.42, Q1 2027 EPS to $3.73 from $3.53, and Q2 2028 EPS to $4.83 from $4.43. The revisions suggest improving expectations for MKS’s earnings trajectory. Zacks Research raises MKS earnings estimates
• Positive Sentiment: Broader earnings-estimate momentum could support the shares. Zacks said solid estimate revisions indicate MKS stock may continue moving higher in the near term. The company’s current-year consensus EPS estimate is $12.96, and its latest reported quarter exceeded analyst expectations for both earnings and revenue. Earnings Estimates Moving Higher for MKS
• Positive Sentiment: Analyst price targets imply substantial potential upside. The average Wall Street target points to approximately 49.8% upside from recent levels. Zacks cautioned, however, that price targets are not always reliable, making the improving earnings outlook a more meaningful potential catalyst. Wall Street Analysts Think MKS Could Surge
• Neutral Sentiment: Mizuho reduced its price target to $330. The revised target remains above recent trading levels, but the cut signals less confidence in MKS’s valuation or near-term upside than previously expected. Mizuho Lowers MKS Price Target
• Negative Sentiment: CEO John Tseng-Chung Lee sold 10,000 shares for roughly $3 million. The insider transaction can weigh on sentiment because it may be interpreted as reduced personal exposure, although it does not necessarily indicate a change in the company’s fundamentals. MKS CEO Share Sale

MKS Company Profile

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.